FDMT 4D Molecular Therapeutics, Inc.

NASDAQ
$15.24

4D Molecular Therapeutics, Inc. (FDMT) Hedge Fund Activity

This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.

Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.

Hedge fund breadth
+33.33
12 buyers / 6 sellers
STRONG BUYING
Funds compared
23
funds with comparable FDMT positions
19 current holders · 20 prior-quarter holders
Net share change
+1.45M
+1.73M added, -282.0K cut
Position activity
3 new 9 increased 2 reduced 4 exited

Most significant moves

Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.

Fund Action Shares changed Change Est. value Portfolio wt. Score
ADAR1 Capital Management Long/Short Growth Sold Out -116.7K -100.0% $1.6M 0.0% 55
CITADEL ADVISORS LLC Quant Increased +423.5K +160.4% $5.6M 0.0% 54
Quadrature Capital Quant Sold Out -32.5K -100.0% $432.6K 0.0% 52
ExodusPoint Capital Management Long/Short Quant Sold Out -15.5K -100.0% $206.5K 0.0% 52
Jain Global Long/Short Quant New +23.5K — $313.0K 0.0% 52
Brevan Howard Capital Management Macro New +176.9K — $2.4M 0.0% 52
Graham Capital Management Quant Macro New +12.0K — $159.6K 0.0% 49
Y-Intercept Quant Sold Out -25.4K -100.0% $338.1K 0.0% 48
D. E. Shaw & Co., Inc. Quant Increased +20.3K +84.6% $270.3K 0.0% 48
Schonfeld Strategic Advisors Long/Short Quant Increased +306.4K +303.0% $4.1M 0.0% 47

Most significant buyers

By move score, not size.

  • CITADEL ADVISORS LLC Increased · +423.5K
  • Jain Global New · +23.5K
  • Brevan Howard Capital Management New · +176.9K
  • Graham Capital Management New · +12.0K
  • D. E. Shaw & Co., Inc. Increased · +20.3K

Most significant sellers

By move score, not size.

  • ADAR1 Capital Management Sold Out · -116.7K
  • Quadrature Capital Sold Out · -32.5K
  • ExodusPoint Capital Management Sold Out · -15.5K
  • Y-Intercept Sold Out · -25.4K
  • Squarepoint Ops LLC Reduced · -36.9K

Hedge fund positions

Fund Tier Shares Previous Change Change % Portfolio wt. Action Score
ADAR1 Capital Management 3 0 116.7K -116.7K -100.0% 0.0% Sold Out 55
CITADEL ADVISORS LLC 1 687.6K 264.1K +423.5K +160.4% 0.0% Increased 54
Quadrature Capital 3 0 32.5K -32.5K -100.0% 0.0% Sold Out 52
ExodusPoint Capital Management 3 0 15.5K -15.5K -100.0% 0.0% Sold Out 52
Jain Global 3 23.5K 0 +23.5K — 0.0% New 52
Brevan Howard Capital Management 3 176.9K 0 +176.9K — 0.0% New 52
Graham Capital Management 3 12.0K 0 +12.0K — 0.0% New 49
Y-Intercept 4 0 25.4K -25.4K -100.0% 0.0% Sold Out 48
D. E. Shaw & Co., Inc. 1 44.4K 24.0K +20.3K +84.6% 0.0% Increased 48
Schonfeld Strategic Advisors 3 407.5K 101.1K +306.4K +303.0% 0.0% Increased 47
Man Group 3 68.3K 29.0K +39.4K +135.8% 0.0% Increased 46
Engineers Gate 4 68.2K 29.4K +38.8K +132.0% 0.0% Increased 42
Squarepoint Ops LLC 2 25.6K 62.5K -36.9K -59.1% 0.0% Reduced 38
ADAGE CAPITAL PARTNERS GP, L.L.C. 2 2.2M 1.6M +644.0K +40.1% 0.0% Increased 37
TWO SIGMA INVESTMENTS, LP 2 69.5K 124.3K -54.8K -44.1% 0.0% Reduced 37
MARSHALL WACE, LLP 2 21.3K 16.7K +4.6K +27.6% 0.0% Increased 32
RENAISSANCE TECHNOLOGIES LLC 1 614.6K 578.3K +36.3K +6.3% 0.0% Increased 29
AQR Capital Management 3 50.3K 45.8K +4.5K +9.8% 0.0% Increased 22
RA Capital Management 1 5.0M 5.0M 0 +0.0% 0.6% Unchanged 28
Biotechnology Value Fund 1 2.9M 2.9M 0 +0.0% 1.0% Unchanged 27
Armistice Capital 3 2.0M 2.0M 0 +0.0% 0.7% Unchanged 20
RTW Investments 1 475.7K 475.7K 0 +0.0% 0.1% Unchanged 25
Woodline Partners LP 2 200.0K 200.0K 0 +0.0% 0.0% Unchanged 18

Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Hedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.